PT
PROTAGONIST THERAPEUTICS INC
PTGX· Health Care· BiotechnologyS&P 600
Close · 10/09/2026
145.16
1D
+0.05%52-week range
57.13 – 160.81
Volume
5,43,100.00
Price history
PTGX
11/08/2026 to 10/09/2026
O 143.29 H 146.51 L 142.00
1W-0.63%
1M-2.11%
3M+37.24%
6M+50.46%
1Y+148.73%
3Y+641.75%
5Y+192.13%
MAX+219.59%
Fundamentals
as of 10/09/2026- Market cap
- $9.39B
- Shares out
- 64.71M
- P/E (trailing)
- 113.29
- P/E (forward)
- -731.71
- EPS (trailing)
- 1.28
- Beta
- 1.79
- Profit margin
- 29.40%
- P/B
- 11.16
- Return on equity
- 9.85%
SEC financial statements
40 quarterly and 12 annual periods through 30/06/2026.
Details
- Ticker
- PTGX
- Index
- SP600
- Sector
- Health Care
- Industry
- Biotechnology
- HQ
- -
Last close 10/09/2026.